key: cord-0707833-9clw269i
authors: Terzi, K.; Kesici, S.; Özsürekci, Y.; Bayrakci, B.
title: Periorbital erythema is a common cutaneous manifestation in COVID‐19
date: 2021-05-12
journal: Clin Exp Dermatol
DOI: 10.1111/ced.14694
sha: 2ce3689608f7c2f7f91580e93de88e643b17663c
doc_id: 707833
cord_uid: 9clw269i

We read the article by D. Andina et al. with great interest. This is an elaborate review on skin manifestations of COVID-19 in children. In general, cutaneous manifestations of COVID-19 are in polymorphic nature. Cutaneous symptoms can be classified as follows; 1) urticarial rash, 2) confluent erythematous/maculopapular/morbilliform rash, 3) papulovesicular exanthem, 4) chilblain-like acral pattern, 5) livedo reticularis/racemosa-like pattern, 6) purpuric "vasculitic" pattern(2). Various cutaneous manifestations of COVID-19 including erythema multiforme, urticaria and Kawasaki disease-like lesions are well discussed by D. Andina et al..

In general, the cutaneous manifestations of COVID-19 are polymorphic nature. The cutaneous symptoms can be classified as: (i) urticarial rash, (ii) confluent erythematous/maculopapular/morbilliform rash, (ii) papulovesicular exanthem, (iv) chilblain-like acral pattern, (v) livedo reticularis/racemosa-like pattern and (vi) purpuric 'vasculitic' pattern. 2 Various cutaneous manifestations of COVID-19 including erythema multiforme, urticaria and Kawasaki disease-like lesions were well discussed in the review, 1 although one feature that we commonly observed in our case series 3 was missing, namely, periorbital erythema.

A recent article by Young et al. 4 stated that the rate of periorbital erythema in patients with COVID-19 infections could be as high as 20%. We believe that periorbital erythema should also be mentioned in this comprehensive review, as this paper has the potential for being a primary resource on the cutaneous manifestations of COVID-19.

We would like to share the image of one of our patients in order to enrich the review's collection (Fig. 1) . This 6-year-old girl presented with the classic symptoms of multisystem inflammatory syndrome in children, including fever, abdominal pain, erythematous rash, conjunctival congestion and strawberry tongue. The levels of acute-phase reactants (ferritin, interleukin-6, procalcitonin and C-reactive protein) were markedly increased, and COVID-19 IgG was positive. The rashes started to fade on the fifth day of immunomodulatory treatment, and the treatment was stopped on the tenth day. 

Skin manifestations of COVID-19 in children: part 2

Skin manifestations associated with COVID-19: current knowledge and future perspectives

Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

Mucocutaneous manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic